MedRx Statistics

Total Valuation

MedRx has a market cap or net worth of JPY 3.61 billion. The enterprise value is 2.06 billion.

Market Cap	3.61B
Enterprise Value	2.06B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

MedRx has 47.50 million shares outstanding. The number of shares has increased by 24.13% in one year.

Current Share Class	47.50M
Shares Outstanding	47.50M
Shares Change (YoY)	+24.13%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	4.46%
Owned by Institutions (%)	7.74%
Float	44.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.94
PB Ratio	2.09
P/TBV Ratio	2.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.86
EV / Sales	7.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.68

Current Ratio	16.68
Quick Ratio	16.05
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -61.79% and return on invested capital (ROIC) is -36.14%.

Return on Equity (ROE)	-61.79%
Return on Assets (ROA)	-34.54%
Return on Invested Capital (ROIC)	-36.14%
Return on Capital Employed (ROCE)	-59.92%
Revenue Per Employee	11.77M
Profits Per Employee	-50.32M
Employee Count	22
Asset Turnover	0.14
Inventory Turnover	0.08

Taxes

In the past 12 months, MedRx has paid 10.00 million in taxes.

Income Tax	10.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.30% in the last 52 weeks. The beta is 0.57, so MedRx's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-48.30%
50-Day Moving Average	64.66
200-Day Moving Average	79.22
Relative Strength Index (RSI)	63.23
Average Volume (20 Days)	863,555

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedRx had revenue of JPY 259.00 million and -1.11 billion in losses. Loss per share was -24.21.

Revenue	259.00M
Gross Profit	258.00M
Operating Income	-1.04B
Pretax Income	-1.10B
Net Income	-1.11B
EBITDA	-999.75M
EBIT	-1.04B
Loss Per Share	-24.21

Full Income Statement

Balance Sheet

The company has 1.55 billion in cash and n/a in debt, giving a net cash position of 1.55 billion or 32.70 per share.

Cash & Cash Equivalents	1.55B
Total Debt	n/a
Net Cash	1.55B
Net Cash Per Share	32.70
Equity (Book Value)	1.73B
Book Value Per Share	36.38
Working Capital	1.55B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	99.61%
Operating Margin	-400.00%
Pretax Margin	-423.55%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MedRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.13%
Shareholder Yield	n/a
Earnings Yield	-30.67%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedRx has an Altman Z-Score of 27.21 and a Piotroski F-Score of 2.

Altman Z-Score	27.21
Piotroski F-Score	2